Skip to content
DataLookout
Menu

Imagion Biosystems, Inc. clinical trial pipeline

Get alerts when Imagion Biosystems, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: MagSense® Human Epidermal Growth Factor Receptor 2 (HER2) Imaging Agent (MSH2IA) Recruitment opened Imagion Biosystems, Inc.Phase 1/2 NCT07885683
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-21 NCT07885683 MagSense® Human Epidermal Growth Factor Receptor 2 (HER2) Imaging Agent (MSH2IA) Phase 1/2 Recruiting

Active trials by phase

Phase 1/2
1

Disease areas by active trials

Get alerts when Imagion Biosystems, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free